Image Credit: Canva
When was the last time you measured your waistline? If you assume that BMI is the only number to focus on when it comes to your health, think twice. New research has revealed a shocking revelation—your waist circumference might be a far better predictor of men's cancer risk than BMI.
The study finds that for each 4-inch increase in waist size, a man's risk of cancer increases by a staggering 25%. Meanwhile, BMI, commonly regarded as the gold standard for assessing obesity, raises cancer risk by only 19% for the same weight gain. So, if you've been dismissing that pesky belly fat, it's time to take notice.
But why is your waistline so important? The reason is visceral fat—the hidden, deep fat that accumulates around your organs. Unlike other body fat, visceral fat is a stealthy troublemaker, causing inflammation, insulin resistance, and abnormal blood fat levels—all of which combine to create a cancer-perfect storm.
Obesity has been associated with an increased risk of numerous health conditions, including cancer, for decades. The research, though, indicates that a specific measure of the body—waist circumference—may be an even more reliable forecaster of cancer risk in men than the more frequently employed Body Mass Index (BMI). This finding emphasizes the need to pay particular attention to the distribution of fat and not merely to the weight of the body.
BMI has been the go-to measure for years for gauging health risks related to obesity. New research, though, that appears in The Journal of the National Cancer Institute indicates that waist measurement is a better predictor of cancer risk in men. According to the research, four more inches (10 cm) around the waist will add 25% to a man's cancer risk. Conversely, a 3.7 kg/m² rise in BMI (from a BMI of 24 to 27.7) increased cancer risk by only 19%.
Why is waist circumference a better predictor, then? Unlike BMI, which measures weight relative to height, waist circumference actually measures abdominal fat—specifically, visceral fat. This type of fat encircles internal organs and is also linked to higher levels of inflammation, insulin resistance, and abnormal blood lipids, all of which are factors in cancer growth. BMI, however, does not measure fat distribution, so two individuals with the same BMI can have very different levels of health risk depending on where fat is deposited on their bodies.
Interestingly, the research identified a significant difference between men and women when it came to waist circumference and cancer risk. Although waist circumference and BMI were linked with obesity-related cancers in women, the relationship was weaker than for men. An increase of 12 cm (4.7 inches) in waist size or a 4.3 rise in BMI (from 24 to 28.3) raised the cancer risk in women by just 13%—a much lower percentage than for men.
Experts credit this difference to the way that fat is stored in the body. Men are more likely to carry fat around the abdomen, especially as visceral fat, which is more metabolically active and associated with cancer-producing biological alterations. Women, by contrast, store fat in peripheral sites such as the hips and thighs, where it is less likely to drive systemic inflammation and metabolic disturbances.
A possible reason is that men tend to depot fat more in the visceral regions, whereas women tend to carry more subcutaneous and peripheral fat," wrote the researchers. "This may render waist circumference a more robust risk factor for cancer in men and account for why waist circumference provides additional risk information beyond BMI in men but not women."
The research used the International Agency for Research on Cancer (IARC) data to define obesity-related cancers. These cancers are esophageal (adenocarcinoma), gastric (cardia), colorectal, rectal, liver, gallbladder, pancreatic, renal, and thyroid cancers, and multiple myeloma and meningioma. In men, abdominal obesity is especially significant in raising the risk of these cancers through high levels of insulin and markers of inflammation.
For women, the research proposes that both waist circumference and hip circumference may give a more accurate estimate of visceral fat and cancer risk. "Adding hip circumference to risk models could strengthen the link between waist circumference and cancer, especially in women," researchers observed.
With these results, doctors advise men to be more mindful of their waistline than only their BMI. Waist size is an easy method to gauge health risk, and its maintenance through lifestyle changes might be the key to cancer prevention.
Track Your Waist Size: Regularly measure your waist circumference and try to keep it in a healthy range (below 40 inches for men, according to medical advice).
Eat a Balanced Diet: A diet containing high fiber, lean protein, and healthy fats can assist in limiting visceral fat gain.
Exercise Consistently: Regular exercise with a combination of aerobic and strength training will help maintain a healthy waistline.
Control Stress and Sleep: Persistent stress and inadequate sleep tend to cause weight gain, especially in the midsection of the body.
Regular Health Screenings: Early identification of cancer risk factors through regular screening can greatly enhance long-term health status.
Credit: iStock
Advances in hematology, oncology, and blood and marrow transplantation (BMT) have transformed patient outcomes over the past two decades. However, alongside these achievements lies a persistent and often underappreciated threat—Invasive Fungal Infections (IFIs).
Despite significant improvements in diagnostics and antifungal therapies, IFIs continue to contribute substantially to morbidity, mortality, prolonged hospitalization, and healthcare costs among immunocompromised patients. Fungal infections in patients with blood cancers and blood disorders are neither rare nor unpredictable. And yet they continue to be diagnosed too late, too often.
The treatments that have transformed the outlook for leukemia, lymphoma, myeloma, and serious bone marrow disorders are genuinely remarkable. Intensive chemotherapy, bone marrow transplantation, and the newer targeted therapies have extended and saved lives in ways that were not imaginable a generation ago. But each of them does something to the immune system that creates a serious risk.
Chemotherapy depletes neutrophils, the white blood cells specifically responsible for recognizing and destroying fungal organisms. A transplant requires conditioning that leaves patients with almost no immune defenses for an extended period. Prolonged neutropenia, mucosal barrier injury, corticosteroid exposure, graft-versus-host disease, and the increasing use of targeted therapies collectively create an environment where opportunistic fungal pathogens can thrive. Some of the most effective modern therapies in hematology work by modifying immune pathways, leaving patients vulnerable to fungal disease for months after treatment ends. This window can last weeks, sometimes much longer.
Aspergillus is a mould found in ordinary dust and soil. In most people, it causes no harm whatsoever. In a patient with severely depleted white blood cells, it can establish a lung infection that progresses faster than most people would expect and carries a mortality rate that remains unacceptably high even with treatment. The earlier it is identified, the better the outcome. But the gap between early and late diagnosis in this context is narrow and unforgiving.
Mucormycosis is less familiar to the public but arguably more aggressive. It invades blood vessel walls directly, cutting off blood supply to surrounding tissue. Patients with blood disorders who require repeated transfusions are at particular risk because excess iron in the body accelerates their growth significantly. India has the highest burden of this infection in the world. That statistic deserves more attention than it currently receives.
Candida lives in the gut of most healthy individuals without causing any problems. When the gut lining is damaged by chemotherapy, it can cross into the bloodstream and reach the liver, spleen, and other organs, causing infections that are difficult to detect and slow to resolve.
Delayed recognition frequently results in disease progression, leading to respiratory failure, disseminated infection, and poor outcomes.
None of these infections begins dramatically. The early signs are a fever that does not settle with antibiotics, a cough without an obvious cause, and breathlessness that seems proportionate to the treatment but lingers too long. In
a patient already unwell from intensive therapy, these signs often get attributed to other causes. Time passes, and the infection progresses.
Specific blood tests can indicate a fungal diagnosis before imaging shows anything definitive. They are not available everywhere in India, and that gap costs lives. Apart from the economic burden of IFIs, it can disrupt cancer treatment schedules, delaying chemotherapy or transplantation and potentially compromising long-term disease control.
Preventive antifungal therapy for high-risk patients has strong evidence behind it. Centers that have built awareness of fungal infection risk into their standard care protocols consistently see better outcomes.
For families, the most important thing is simply knowing this risk exists. Asking about it is entirely reasonable. Expecting it to be actively managed is also reasonable. In hematology and oncology, the infections that go unrecognised are the ones that do most of the damage.
Invasive fungal infections are not merely infectious complications; they are major determinants of outcomes in modern hematology and oncology practice. Recognizing the hidden burden of IFIs is the first step toward reducing their impact and improving outcomes for our most vulnerable patients.
Credit: AI-generated image
Men have been taught for generations that they must be strong, that they are supposed to be self-sufficient, not to feel any impact, and to be emotionally strong when they face challenges.
Resilience is a good trait, but it may also make men feel disheartened about sharing their vulnerabilities or asking for assistance when they need it. Emotional distress can often be seen as a personal failure, rather than a health issue, as many grow up hearing "man up" or "be strong.”
Meanwhile, there is still a high demand for men in society. Financial pressures, career expectations, family commitments, and social expectations can become a never-ending burden.
These factors can lead to feelings of loneliness, worry, and sadness, especially when combined with not having enough emotional release and wanting to turn to others for help.
Men are expected to be a part of the discussion, but not the central point of discussion when it comes to mental health. But the figures don't match. Almost three-fourths of the suicides in India are committed by men, which is a hidden and unaddressed issue.
One of the major issues is that there is a definition of masculinity in society. Boys are taught to be tough and independent from a young age and do not have to show feelings. The traits can both assist people in coping with difficulties and hinder them from admitting to emotional problems or seeking help when it is most necessary.
Read more: Doctors Day: From Burnout To Work Anxiety, The Mental Health Struggle Doctors Rarely Talk About
A further issue is that there are not enough safe places in which men can express feelings without risk of condemnation. Stigma can be a barrier to seeking help even when there is help available. This can not only postpone treatment but also increase symptoms of loneliness and hopelessness.
The answer is more than just asking men to "speak up". We need to actively question and combat the stereotypes entrenched in society that equate vulnerability with weakness. Both families and workplaces, schools and communities all have a part to play in promoting emotional literacy and open dialogue amongst men.
Men may not be aware of or express emotional distress in traditional ways, which can be a big problem. Rather, symptoms can be manifested as irritability, withdrawal, substance abuse, or risk-taking behaviour, which can make it difficult for family members and friends to recognise when intervention is required.
It is not enough to raise awareness to solve this crisis. It is important to establish a space of normalisation for expressing emotions, to provide support for mental health and to make it part of the identity to seek help instead of looking weak. Promoting the mental health of men is not only an individual matter, but also a public health issue that can save lives.
For a genuine commitment to the prevention of suicide, mental health status of men needs to be a public health issue. Being sensitive to their challenges, to the idea of seeking assistance, and to establishing environments that are supportive of them can make the difference between life and death.
By Dr. Hamza Hussain, Head of the Department of Psychiatry and Mental Health at Ruby Hall Clinic and Bhavya Shah, Consultant Psychologist at Saifee Hospital, Mumbai
Credits: Canva
Cancer cases are rising across India, but many patients still reach hospitals only after the disease has advanced. According to Dr. Hasmukh Jain, Professor of Medical Oncology at Tata Memorial Hospital, Mumbai, recognizing persistent warning signs and seeking timely medical care can make a critical difference.
Speaking about cancer awareness, Dr. Jain said, "Every year 15 lakh new cases of cancer are diagnosed in India. But the unfortunate thing is that most of these cases are diagnosed at an advanced stage."
He stressed that while cancer can present in many different ways, paying attention to your body's signals is one of the most important steps toward early diagnosis.
Dr. Jain explained that cancer often begins with symptoms that are common to many other illnesses, making them easy to dismiss. These may include:
Although these symptoms may also occur due to infections or conditions such as tuberculosis, he advised against ignoring them.
"If the symptoms are persisting for more than two weeks, always seek medical attention," Dr. Jain said.
He added that many cancers can be detected through a physical examination, basic blood tests, and, when required, a biopsy.
Also Read: FSSAI Targets 6 Energy Drink Brands; Experts Link Them to Obesity, Liver Problems
Cancer cases are increasing at an alarming rate, both in India and globally. To combat this, embracing healthy lifestyle practices can significantly reduce the risk of this life-threatening disease.
Here are some of the everyday habits that one can follow to reduce the risk of cancer:
Consuming a healthy and balanced diet rich in fruits, vegetables, whole grains, and lean proteins can reduce cancer risk. Berries, nuts, and green leafy vegetables contain many antioxidant properties that are useful in fighting oxidative stress-induced cancer. Cutting back and eliminating red and processed meat and sugar-containing drinks lowers the risk further.
Regular physical activity keeps the individual body fit and reduces the risk of breast, colon, and endometrial cancers.
Among the factors that would be measured when determining preventable causes, tobacco use takes part as the first head in the index, associated with lung, throat, or mouth cancers. Similarly, alcohol consumption exposure is linked to many cancers, from hepatocellular to breast cancer. Moderation or abstinence is the key.
Skin cancer is one of the most preventable types of cancer. Applying sunscreen with high SPF, finding shade, and avoiding tanning beds would save you from harmful ultraviolet rays.
Most people, including men and women over the age of 40, should get routine screening through mammograms, Pap tests, and colonoscopy to enhance early detection, which can save lives.
Moreover, cancer prevention is a shared goal influenced by personal choices. Bringing small yet steady changes in daily habits can dramatically reduce cancer risk while enhancing quality of life.
© 2024 Bennett, Coleman & Company Limited